Rialto Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$680K Buy
5,295
+70
+1% +$8.19K 0.13% 96
2026
Q1
$629K Buy
5,225
+47
+0.9% +$5.43K 0.14% 95
2025
Q4
$545K Buy
5,178
+42
+0.8% +$3.94K 0.13% 96
2025
Q3
$431K Sell
5,136
-210
-4% -$17.3K 0.11% 100
2025
Q2
$423K Sell
5,346
-24
-0.4% -$1.91K 0.12% 100
2025
Q1
$482K Buy
5,370
+27
+0.5% +$2.52K 0.15% 95
2024
Q4
$532K Buy
+5,343
New +$551K 0.18% 87

Other funds holding MRK

Rialto Wealth Management's MRK Position: Q2 2026 in Review

Rialto Wealth Management increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $8.19K and bringing the position to 5,295 shares worth $680K. The position accounts for 0.13% of the portfolio, ranked #96.

Rialto Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rialto Wealth Management held 5,295 shares of Merck worth $680K as of Q2 2026.
  • Rialto Wealth Management bought 70 Merck shares in Q2 2026, an estimated $8.19K.
  • Merck made up 0.13% of Rialto Wealth Management's portfolio in Q2 2026, its #96 holding.
  • Rialto Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.